(TAKEN FROM APPLICANT): Objective:
The aim of the proposed randomized controlled study is to assess the efficacy and effectiveness of acupuncture treatment of depression during pregnancy. Significance: Depression is, unfortunately common during pregnancy and it has significant deleterious effects on mother and infant, including low birth weight, preterm delivery, and continued depression into postpartum. Few medically acceptable treatments are available for the treatment of depression during pregnancy. Our preliminary work provides evidence that acupuncture may be a safe and acceptable treatment option for depression.
Specific aims : 1) to evaluate the efficacy of brief 8-week treatment with SPEC acupuncture for major depression during pregnancy relative to the two control treatments; 2) to evaluate the efficacy and clinical significance (pregnancy outcome) of continued treatment with SPEC acupuncture relative to the two control treatments; and 3) to evaluate the differential impact of treatment with SPEC acupuncture for major depression on the incidence of postpartum depression. Participants. Design: To test the efficacy of acupuncture designed specifically to address depressive symptomatology during pregnancy (SPEC) it will be compared, using random assignment, to the following 2 control conditions: 1) valid acupuncture that does not directly address depressive symptoms (NSPEC), thus controlling for the belief in the efficacy of the treatment; and 2) prenatal massage (MSSG), thus controlling for attention, physical contact, relaxation and respite from daily stress. The study includes three phases, acute, continuation and follows up. Participants: 180 participants meeting western diagnostic criteria for Major Depression with a score >: 14 on the first 17 items of the 24-item Hamilton Depression Rating Scale (HRSD) will be randomized. The ethnic distribution of the sample will be representative of the ethnic distribution in the San Francisco Bay Area. Treatments: The acute phase of treatment consists of 16 half-hour treatment sessions delivered over 8 weeks. To consolidate treatment gains and to prevent post partum depression, participants who have full or partial response at the end of the acute phase will continue to receive the same, but less frequent, treatment until 10 weeks post partum, and will be followed up for 6 more months. Main Outcome Measure(s): The primary outcome measures are the HRSD and the depression portion of the SCID-IV, to be administered monthly during the treatment phases and at 3 and 6 months follow up. Other important measures include the Beck Depression Inventory (weekly), expectations (of the participants and the providers), and delivery and infant measures.
| Lyell, Deirdre J; Chambers, Andrea S; Steidtmann, Dana et al. (2012) Antenatal identification of major depressive disorder: a cohort study. Am J Obstet Gynecol 207:506.e1-6 |
| Tikotzky, Liat; Chambers, Andrea S; Gaylor, Erika et al. (2010) Maternal sleep and depressive symptoms: links with infant Negative Affectivity. Infant Behav Dev 33:605-12 |
| Manber, Rachel; Schnyer, Rosa N; Lyell, Deirdre et al. (2010) Acupuncture for depression during pregnancy: a randomized controlled trial. Obstet Gynecol 115:511-20 |
| Manber, R; Blasey, C; Allen, J J B (2008) Depression symptoms during pregnancy. Arch Womens Ment Health 11:43-8 |
| Manber, Rachel; Schnyer, Rosa N; Allen, John J B et al. (2004) Acupuncture: a promising treatment for depression during pregnancy. J Affect Disord 83:89-95 |
| Manber, Rachel; Chambers, Andrea S; Hitt, Sabrina K et al. (2003) Patients' perception of their depressive illness. J Psychiatr Res 37:335-43 |
| Manber, Rachel; Allen, John J B; Morris, Margaret E et al. (2002) Alternative treatments for depression: empirical support and relevance to women. J Clin Psychiatry 63:628-40 |
| Schnyer, Rosa N; Allen, John J B (2002) Bridging the gap in complementary and alternative medicine research: manualization as a means of promoting standardization and flexibility of treatment in clinical trials of acupuncture. J Altern Complement Med 8:623-34 |
